# Almirall Hermal GmbH – FDA Inspection, Mar 29, 2019

Source: https://www.keypedia.com/records/fda_inspections/almirall-hermal-gmbh/7eaa2076-6b92-43bf-9bd5-25c82ca8f245
Source feed: FDA_Inspections

> FDA inspection 1086417 of Almirall Hermal GmbH, March 29, 2019. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086417
- Company Name: Almirall Hermal GmbH
- Inspection Date: 2019-03-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- FDA Inspection 1270072 - 2021-05-06
- FDA Inspection 898000 - 2014-09-26
- [FDA Inspection 779008 - 2012-04-13](https://www.keypedia.com/records/fda_inspections/almirall-hermal-gmbh/c4d61820-f95c-4d3e-850c-78da5ef5c6c3)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/doan-n-singh/e52cfbca-5710-4765-8c5e-d534946b648d)

Company: https://www.keypedia.com/companies/almirall-hermal-gmbh/7dc49f53-7009-47cf-82b2-64a2ab60f36c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c